News for Sartorius Stedim Biotech S.A. (SDMHF)

Sartorius Stedim Biotech S.A. (OTCPK:SDMHF) Q3 2024 Earnings Conference Call October 17, 2024 7:00 AM ETCompany ParticipantsJoachim Kreuzburg - ChairmanRené...

Sartorius Stedim Biotech S.A. (SDMHF) reports Q3 GAAP EPS of €0.26 and revenue of €655.4M, with a positive outlook for fiscal 2024 profitability.

The global pharmaceutical filtration market size is anticipated to grow from USD 12.47 billion to USD 19.55 billion in 10 years. The market will experience...

Invesco Oppenheimer International Growth Fund Class A shares at NAV declined during the quarter while the MSCI ACWI ex-US Index’s posted a gain. Click here to read the full fund letter.

Sartorius Stedim Biotech S.A. (OTCPK:SDMHF) H1 2024 Earnings Conference Call July 18, 2024 1:45 AM ETCompany ParticipantsDr.

The following slide deck was published by Sartorius Stedim Biotech S.A.

Latest Spring earnings showed that the Top 5 Publicly Traded Life Science tool companies by market cap decreased total revenues in the high to low single digits YOY in the January – March Quarter, according to their Latest Earnings Releases. Of the publicly traded Life Science tool companies who released earnings results, the following top …

At today's combined Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A., shareholders have granted discharge to all directors by a large majority and approved the renewal of the...

Absent a black swan event such as a new pandemic, Sartorius AG trades at far too high multiples. Read more to see our analysis on SARTF stock.

Latest Winter earnings showed that the Top 5 Publicly Traded Life Science tool companies by market cap decreased total revenues in the high to low teens YOY in the October – December Quarter, according to the Latest Earnings Releases. Of the publicly traded Life Science tool companies who released earnings results, the following top 5 …

EQS-Ad-hoc: SARTORIUS AG / Key word: Transaction in Own Shares SARTORIUS AG: Sartorius launches placement of up to 200 million euros of treasury preference shares through accelerated...

We share the heat map of the most investable candidates that may be worth your time for further analysis. Read more to see The October 2023 Heat Map.

/PRNewswire/ -- The "Chromatography Resin Market by Type, Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Mixed Mode), Application...

/PRNewswire/ -- The Frost & Sullivan Institute's Enlightened Growth Leadership Best Practices Recognition honors Companies that represent the top 1% of all...

According to Strategic Market Research, 3D cell culture market was worth USD 1.43 billion in 2020 and is likely to reach a landmark of nearly USD 6.47...

Sartorius Stedim Biotech, a leading partner of the biopharma industry, recorded exceptionally strong growth in 2020 that was driven by strong organic development, several acquisitions and additional momentum from business related to the coronavirus pandemic. According to preliminary figures, the Group closed the year with significant double-digit growth rates in sales revenue, order intake and earnings, recording further gains across all geographies.

AUBAGNE, France, Jan. 27, 2021 /PRNewswire/ -- Sartorius Stedim Biotech, a leading partner of the biopharma industry, recorded exceptionally strong growth ...

France stocks lower at close of trade; CAC 40 down 1.63%

France stocks lower at close of trade; CAC 40 down 0.71%